Developer docs
API playgroundTry for free, no card

Search company profiles

Biorbis

Full company profile

uuid00qfotn

Namestring
Biorbis
Legal namestring
Biorbis
Websiteurl
biorbis.com.pt
Company typeenum
Private
Founded yearint
2023
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPorto, Portugal
HQ citystring
Porto
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation, industrial biotechnology, biomanufacturing services, enzyme development, R&D partnerships
Industry4 codes
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Industrial Biotechnology R&D Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1R&D Partnership Services
TypeProfessional Services
Description

Biorbis generates revenue through R&D partnership contracts with global companies, providing innovation services from discovery through pilot validation to commercial scale-up. Projects are structured around specific client problems and process requirements.

biorbis.com.pt
2Contract Manufacturing Development
TypeManaged Services
Description

As the innovation engine for Magdalena's Biochem Unit, Biorbis supports contract manufacturing organization activities for the biotech industry, including enzyme and protein ingredient development.

biorbis.com.pt
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
Pricing details1 tier
1Custom project-based pricing for enterprise clients
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing negotiated per project based on scope, complexity, and specific client requirements.

biorbis.com.pt
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biorbis is an R&D and innovation lab that designs and develops high-value molecules, enzymes, and peptides for industrial biotechnology applications. The company operates as an R&D partner and innovation engine, helping global companies translate molecular discoveries into commercially viable products through precision fermentation. It serves as the dedicated R&D laboratory for Magdalena's BioChem Unit, providing end-to-end services spanning breakthrough discovery, competitive process design, pilot validation, and industrial-scale production across animal feed, pet food, aquaculture, nutrition, biochemical, and cosmetic markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biorbis is an R&D innovation lab and service provider that operates as the innovation engine for global companies and serves as the R&D partner of Magdalena's BioChem Unit. Rather than offering a discrete product suite, Biorbis provides a structured service offering across four integrated phases: Innovate (breakthrough discovery and creation), Develop (competitive process design), Scale (from concept to market-ready), and Grow (sustainable solutions delivered at scale). The company specializes in precision fermentation, working with molecules, enzymes, and peptides to create high-performing functional solutions for animal feed, pet food, aquaculture, human nutrition and wellness, biochemicals, and skin care and cosmetics markets. Biorbis bridges discovery and biomanufacturing, enabling clients to transition from lab insights to industrial-scale production.

Product and service4 records
1Innovate - Breakthrough Discovery & Creation
CategoryBiotechnology R&D Services
2Develop - Competitive Process Design
3Scale - From Concept to Market-Ready
4Grow - Sustainable Solutions Delivered at Scale
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biorbis is the R&D partner and innovation engine of Magdalena's BioChem Unit. Magdalena is a Guatemalan sugar producer founded in 1983, family-owned, that is diversifying from commodity sugar into precision fermentation and biomanufacturing. Biorbis serves as the dedicated R&D laboratory supporting Magdalena's strategic shift toward high-value biological manufacturing including industrial enzymes and protein ingredients.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeOthers
Description

bioMérieux is a major provider of in vitro diagnostics and industrial microbiology solutions. Relevant adjacent peer given the bioassay and cellular analytical work Biorbis describes, though not a direct competitor in R&D services.

TypeBroad incumbent
Description

Novozymes is the world's largest industrial enzyme producer with broad capabilities in precision fermentation. Comparable to Biorbis as a large-scale player in enzyme and protein ingredients, but operates at vastly greater scale across the same end-markets including animal feed and food.

TypeEmerging player
Description

Codexis engineers enzymes and proteins using directed evolution for pharmaceutical, food, and industrial applications. Comparable to Biorbis in the enzyme engineering and protein ingredient development domains, with overlap in nutraceutical and pharmaceutical customer bases.

TypeOthers
Description

Eurofins is a global leader in bioanalytical testing and laboratory services across food, feed, environmental, and pharmaceutical sectors. Comparable as an analytical services provider in the same end-markets Biorbis serves, providing complementary rather than competing capabilities.

TypeBroad incumbent
Description

DSM-Firmenich is a global science-based company active in nutrition, health, and beauty with significant precision fermentation capabilities. Comparable to Biorbis across multiple target end-markets (animal nutrition, human nutrition, personal care) as a large established incumbent.

TypeEmerging player
Description

LanzaTech uses precision fermentation (gas fermentation) to produce sustainable chemicals and fuels. Comparable to Biorbis in the renewable biochemicals space and in developing scalable industrial bioprocesses, though focused on different feedstocks.

TypeEmerging player
Description

Twist Bioscience provides synthetic DNA and DNA-based products enabling synthetic biology applications. Comparable as a synthetic biology platform company, though focused more on enabling tools than on end-to-end fermentation process development like Biorbis.

TypeDirect peer
Description

Conagen is a precision fermentation company developing ingredients for food, nutrition, beauty, and pharmaceutical markets through its proprietary strain engineering platform. Comparable to Biorbis in both technology (precision fermentation) and target markets (nutrition, cosmetics, biochemicals).

TypeDirect peer
Description

Ginkgo operates a synthetic biology platform providing cell engineering and R&D services to enterprise customers across multiple end-markets including food, nutrition, and industrial biotech. Directly comparable as a B2B R&D services platform using precision fermentation to develop molecules for global brands.

10Culture Biosciences
TypeDirect peer
Description

Culture Biosciences provides fermentation process development and manufacturing services as a CDMO for biotech companies. Comparable as a B2B precision fermentation services provider helping clients scale bioprocesses from lab to commercial production.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biorbis

Industrial Biotechnology R&D Servicesbiorbis.com.pt

Biorbis firmographics

Firmographics
Name
Biorbis
Legal name
Biorbis
Website
https://biorbis.com.pt
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Biorbis industry classification

Industry
Product category
Industrial Biotechnology R&D Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Precision fermentation
  • Industrial biotechnology
  • Biomanufacturing services
  • Enzyme development
  • R&D partnerships

Where Biorbis is headquartered

Location

Headquarters

HQ city
Porto
HQ country
Portugal
HQ region
Europe

Offices1 record

Markets served

Biorbis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. R&D Partnership Services: Biorbis generates revenue through R&D partnership contracts with global companies, providing innovation services from discovery through pilot validation to commercial scale-up. Projects are structured around specific client problems and process requirements.
  2. Contract Manufacturing Development: As the innovation engine for Magdalena's Biochem Unit, Biorbis supports contract manufacturing organization activities for the biotech industry, including enzyme and protein ingredient development.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing for enterprise clients

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Biorbis product offering

Product offering

Core offering

Biorbis is an R&D and innovation lab that designs and develops high-value molecules, enzymes, and peptides for industrial biotechnology applications. The company operates as an R&D partner and innovation engine, helping global companies translate molecular discoveries into commercially viable products through precision fermentation. It serves as the dedicated R&D laboratory for Magdalena's BioChem Unit, providing end-to-end services spanning breakthrough discovery, competitive process design, pilot validation, and industrial-scale production across animal feed, pet food, aquaculture, nutrition, biochemical, and cosmetic markets.

Product overview

Biorbis is an R&D innovation lab and service provider that operates as the innovation engine for global companies and serves as the R&D partner of Magdalena's BioChem Unit. Rather than offering a discrete product suite, Biorbis provides a structured service offering across four integrated phases: Innovate (breakthrough discovery and creation), Develop (competitive process design), Scale (from concept to market-ready), and Grow (sustainable solutions delivered at scale). The company specializes in precision fermentation, working with molecules, enzymes, and peptides to create high-performing functional solutions for animal feed, pet food, aquaculture, human nutrition and wellness, biochemicals, and skin care and cosmetics markets. Biorbis bridges discovery and biomanufacturing, enabling clients to transition from lab insights to industrial-scale production.

Differentiator

Problem solved

Functional benefit

Products and services

  • Innovate - Breakthrough Discovery & Creation
  • Develop - Competitive Process Design
  • Scale - From Concept to Market-Ready
  • Grow - Sustainable Solutions Delivered at Scale

Companies that use Biorbis

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Biorbis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Biorbis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Magdalena BioChem UnitcoreStrategic or Co-development PartnerBiorbis is the R&D partner and innovation engine of Magdalena's BioChem Unit. Magdalena is a Guatemalan sugar producer founded in 1983, family-owned, that is diversifying from commodity sugar into precision fermentation and biomanufacturing. Biorbis serves as the dedicated R&D laboratory supporting Magdalena's strategic shift toward high-value biological manufacturing including industrial enzymes and protein ingredients.

Scale indicators1 record

Recent moves4 records

Biorbis competitors and assessment

Company assessment

Others

  • bioMérieux: bioMérieux is a major provider of in vitro diagnostics and industrial microbiology solutions. Relevant adjacent peer given the bioassay and cellular analytical work Biorbis describes, though not a direct competitor in R&D services.
  • Eurofins Scientific: Eurofins is a global leader in bioanalytical testing and laboratory services across food, feed, environmental, and pharmaceutical sectors. Comparable as an analytical services provider in the same end-markets Biorbis serves, providing complementary rather than competing capabilities.

Broad incumbents

  • Novozymes: Novozymes is the world's largest industrial enzyme producer with broad capabilities in precision fermentation. Comparable to Biorbis as a large-scale player in enzyme and protein ingredients, but operates at vastly greater scale across the same end-markets including animal feed and food.
  • dsm-firmenich: DSM-Firmenich is a global science-based company active in nutrition, health, and beauty with significant precision fermentation capabilities. Comparable to Biorbis across multiple target end-markets (animal nutrition, human nutrition, personal care) as a large established incumbent.

Emerging players

  • Codexis: Codexis engineers enzymes and proteins using directed evolution for pharmaceutical, food, and industrial applications. Comparable to Biorbis in the enzyme engineering and protein ingredient development domains, with overlap in nutraceutical and pharmaceutical customer bases.
  • LanzaTech: LanzaTech uses precision fermentation (gas fermentation) to produce sustainable chemicals and fuels. Comparable to Biorbis in the renewable biochemicals space and in developing scalable industrial bioprocesses, though focused on different feedstocks.
  • Twist Bioscience: Twist Bioscience provides synthetic DNA and DNA-based products enabling synthetic biology applications. Comparable as a synthetic biology platform company, though focused more on enabling tools than on end-to-end fermentation process development like Biorbis.

Direct peers

  • Conagen: Conagen is a precision fermentation company developing ingredients for food, nutrition, beauty, and pharmaceutical markets through its proprietary strain engineering platform. Comparable to Biorbis in both technology (precision fermentation) and target markets (nutrition, cosmetics, biochemicals).
  • Ginkgo Bioworks: Ginkgo operates a synthetic biology platform providing cell engineering and R&D services to enterprise customers across multiple end-markets including food, nutrition, and industrial biotech. Directly comparable as a B2B R&D services platform using precision fermentation to develop molecules for global brands.
  • Culture Biosciences: Culture Biosciences provides fermentation process development and manufacturing services as a CDMO for biotech companies. Comparable as a B2B precision fermentation services provider helping clients scale bioprocesses from lab to commercial production.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Biorbis social profiles

Digital presence

Biorbis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biorbis leadership team

Management profile

Number of profiles

Profiles6 records

Biorbis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biorbis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biorbis

What does Biorbis do?

Biorbis is an R&D and innovation lab that designs and develops high-value molecules, enzymes, and peptides for industrial biotechnology applications. The company operates as an R&D partner and innovation engine, helping global companies translate molecular discoveries into commercially viable products through precision fermentation. It serves as the dedicated R&D laboratory for Magdalena's BioChem Unit, providing end-to-end services spanning breakthrough discovery, competitive process design, pilot validation, and industrial-scale production across animal feed, pet food, aquaculture, nutrition, biochemical, and cosmetic markets.

Is Biorbis a public or private company?

Biorbis is a private company. It is classified as corporate owned and is currently operating.

When was Biorbis founded?

Biorbis was founded in 2023. It employs 11 to 50 people.

Where is Biorbis based?

Biorbis is headquartered in Porto, Portugal, in the Europe region.

How does Biorbis make money?

Two revenue lines are on record. R&D Partnership Services are the primary driver. The others are contract Manufacturing Development.

Who are Biorbis's main competitors?

Others on record are bioMérieux and Eurofins Scientific. Broad incumbents are Novozymes and dsm-firmenich. Emerging players are Codexis, LanzaTech and Twist Bioscience. Direct peers are Conagen, Ginkgo Bioworks and Culture Biosciences.

Does Biorbis have an API?

No public API is recorded for Biorbis.

What industry is Biorbis in?

Biorbis's product category is Industrial Biotechnology R&D Services. Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling), with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals